Dataset related to the article "First-line therapy: insights from a real-world analysis of cryoablation in patients with atrial fibrillation" Article Swipe
Massimo Moltrasio
,
Saverio Iacopino
,
Giuseppe Arena
,
Paolo Pieragnoli
,
Giulio Molon
,
Massimiliano Manfrin
,
Roberto Verlato
,
Luca Ottaviano
,
Giovanni Rovaris
,
Domenico Catanzariti
,
Laura Cipolletta
,
Daniele Nicolis
,
Giuseppe Cattafi
,
Claudio Tondo
,
STOP ClinicalService Centers
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.5281/zenodo.6337499
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.5281/zenodo.6337499
This record contains raw data related to the article "First-line therapy: insights from a real-world analysis of cryoablation in patients with atrial fibrillation" Abstract Aims: Pulmonary vein isolation (PVI) using cryoballoon ablation (CBA) is mainly reserved for patients with drug-refractory or drug-intolerant symptomatic atrial fibrillation. We evaluated a large cohort of patients treated in a real-world setting and examined the safety and efficacy profile of CBA when applied as a first-line treatment for atrial fibrillation. Methods: In total, 249 patients (23% women; 56 ± 13 years; mean left atrial diameter 41 ± 7 mm; 73.5% paroxysmal atrial fibrillation; and 26.5% persistent atrial fibrillation) underwent an index PVI by CBA. Data were collected prospectively in the framework of the 1STOP ClinicalService project, involving 26 Italian cardiology centers. Results: Median procedure and fluoroscopy times were 90.0 and 21.0 min, respectively. Acute procedural success was 99.8%. Acute/periprocedural complications were observed in seven patients (2.8%), including: four transient diaphragmatic paralyses, one pericardial effusion (not requiring any intervention), one transient ischemic attack, and one minor vascular complication. The Kaplan--Meier freedom from atrial fibrillation recurrence was 86.3% at 12 months and 76% at 24 months. Seventeen patients (6.8%) had a repeat catheter ablation procedure during the follow-up period. At last follow-up, 10% of patients were on an anticoagulation therapy, whereas 6.8% were on an antiarrhythmic drug. Conclusion: In our multicenter real-world experience, PVI by CBA in a first-line atrial fibrillation patient population was well tolerated, effective, and promising. CBA with a PVI strategy can be used to treat patients with paroxysmal and persistent atrial fibrillation with good acute procedural success, short procedure times, and acceptable safety. Clinical trial registration: clinicaltrials.gov (NCT01007474).
Related Topics
Concepts
Metadata
- Type
- dataset
- Language
- en
- Landing Page
- https://doi.org/10.5281/zenodo.6337499
- OA Status
- green
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4394057272
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4394057272Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.5281/zenodo.6337499Digital Object Identifier
- Title
-
Dataset related to the article "First-line therapy: insights from a real-world analysis of cryoablation in patients with atrial fibrillation"Work title
- Type
-
datasetOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-03-08Full publication date if available
- Authors
-
Massimo Moltrasio, Saverio Iacopino, Giuseppe Arena, Paolo Pieragnoli, Giulio Molon, Massimiliano Manfrin, Roberto Verlato, Luca Ottaviano, Giovanni Rovaris, Domenico Catanzariti, Laura Cipolletta, Daniele Nicolis, Giuseppe Cattafi, Claudio Tondo, STOP ClinicalService CentersList of authors in order
- Landing page
-
https://doi.org/10.5281/zenodo.6337499Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.5281/zenodo.6337499Direct OA link when available
- Concepts
-
Cryoablation, Atrial fibrillation, Internal medicine, Line (geometry), Medicine, Cardiology, Mathematics, Ablation, GeometryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4394057272 |
|---|---|
| doi | https://doi.org/10.5281/zenodo.6337499 |
| ids.doi | https://doi.org/10.5281/zenodo.6337499 |
| ids.openalex | https://openalex.org/W4394057272 |
| fwci | 0.0 |
| type | dataset |
| title | Dataset related to the article "First-line therapy: insights from a real-world analysis of cryoablation in patients with atrial fibrillation" |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10065 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.6621999740600586 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2705 |
| topics[0].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[0].display_name | Atrial Fibrillation Management and Outcomes |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2777628079 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9275583028793335 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q202448 |
| concepts[0].display_name | Cryoablation |
| concepts[1].id | https://openalex.org/C2779161974 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7356662750244141 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q815819 |
| concepts[1].display_name | Atrial fibrillation |
| concepts[2].id | https://openalex.org/C126322002 |
| concepts[2].level | 1 |
| concepts[2].score | 0.44542211294174194 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[2].display_name | Internal medicine |
| concepts[3].id | https://openalex.org/C198352243 |
| concepts[3].level | 2 |
| concepts[3].score | 0.4413463771343231 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q37105 |
| concepts[3].display_name | Line (geometry) |
| concepts[4].id | https://openalex.org/C71924100 |
| concepts[4].level | 0 |
| concepts[4].score | 0.41797754168510437 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[4].display_name | Medicine |
| concepts[5].id | https://openalex.org/C164705383 |
| concepts[5].level | 1 |
| concepts[5].score | 0.35810595750808716 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q10379 |
| concepts[5].display_name | Cardiology |
| concepts[6].id | https://openalex.org/C33923547 |
| concepts[6].level | 0 |
| concepts[6].score | 0.06737473607063293 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q395 |
| concepts[6].display_name | Mathematics |
| concepts[7].id | https://openalex.org/C2778902805 |
| concepts[7].level | 2 |
| concepts[7].score | 0.06407713890075684 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q322177 |
| concepts[7].display_name | Ablation |
| concepts[8].id | https://openalex.org/C2524010 |
| concepts[8].level | 1 |
| concepts[8].score | 0.0 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q8087 |
| concepts[8].display_name | Geometry |
| keywords[0].id | https://openalex.org/keywords/cryoablation |
| keywords[0].score | 0.9275583028793335 |
| keywords[0].display_name | Cryoablation |
| keywords[1].id | https://openalex.org/keywords/atrial-fibrillation |
| keywords[1].score | 0.7356662750244141 |
| keywords[1].display_name | Atrial fibrillation |
| keywords[2].id | https://openalex.org/keywords/internal-medicine |
| keywords[2].score | 0.44542211294174194 |
| keywords[2].display_name | Internal medicine |
| keywords[3].id | https://openalex.org/keywords/line |
| keywords[3].score | 0.4413463771343231 |
| keywords[3].display_name | Line (geometry) |
| keywords[4].id | https://openalex.org/keywords/medicine |
| keywords[4].score | 0.41797754168510437 |
| keywords[4].display_name | Medicine |
| keywords[5].id | https://openalex.org/keywords/cardiology |
| keywords[5].score | 0.35810595750808716 |
| keywords[5].display_name | Cardiology |
| keywords[6].id | https://openalex.org/keywords/mathematics |
| keywords[6].score | 0.06737473607063293 |
| keywords[6].display_name | Mathematics |
| keywords[7].id | https://openalex.org/keywords/ablation |
| keywords[7].score | 0.06407713890075684 |
| keywords[7].display_name | Ablation |
| language | en |
| locations[0].id | doi:10.5281/zenodo.6337499 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4306400562 |
| locations[0].source.issn | |
| locations[0].source.type | repository |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Zenodo (CERN European Organization for Nuclear Research) |
| locations[0].source.host_organization | https://openalex.org/I67311998 |
| locations[0].source.host_organization_name | European Organization for Nuclear Research |
| locations[0].source.host_organization_lineage | https://openalex.org/I67311998 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | |
| locations[0].raw_type | dataset |
| locations[0].license_id | |
| locations[0].is_accepted | False |
| locations[0].is_published | |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.5281/zenodo.6337499 |
| indexed_in | datacite |
| authorships[0].author.id | https://openalex.org/A5070150109 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8891-6237 |
| authorships[0].author.display_name | Massimo Moltrasio |
| authorships[0].countries | IT |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210089474 |
| authorships[0].affiliations[0].raw_affiliation_string | Centro Cardiologico Monzino IRCCS |
| authorships[0].institutions[0].id | https://openalex.org/I4210089474 |
| authorships[0].institutions[0].ror | https://ror.org/006pq9r08 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210089474, https://openalex.org/I4210153126 |
| authorships[0].institutions[0].country_code | IT |
| authorships[0].institutions[0].display_name | Centro Cardiologico Monzino |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Massimo Moltrasio |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Centro Cardiologico Monzino IRCCS |
| authorships[1].author.id | https://openalex.org/A5067195227 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-2131-1110 |
| authorships[1].author.display_name | Saverio Iacopino |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Saverio Iacopino |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5009909916 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-0266-6493 |
| authorships[2].author.display_name | Giuseppe Arena |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Giuseppe Arena |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5103168065 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1363-1947 |
| authorships[3].author.display_name | Paolo Pieragnoli |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Paolo Pieragnoli |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5056782644 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-8287-0461 |
| authorships[4].author.display_name | Giulio Molon |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Giulio Molon |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5040652980 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-0387-8850 |
| authorships[5].author.display_name | Massimiliano Manfrin |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Massimiliano Manfrin |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5047081960 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-9650-4507 |
| authorships[6].author.display_name | Roberto Verlato |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Roberto Verlato |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5019010269 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-1496-8963 |
| authorships[7].author.display_name | Luca Ottaviano |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Luca Ottaviano |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5078874877 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-5639-5708 |
| authorships[8].author.display_name | Giovanni Rovaris |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Giovanni Rovaris |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5007042709 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-2020-2753 |
| authorships[9].author.display_name | Domenico Catanzariti |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Domenico Catanzariti |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5066920995 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-7570-4278 |
| authorships[10].author.display_name | Laura Cipolletta |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Laura Cipolletta |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5046309577 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Daniele Nicolis |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Daniele Nicolis |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5113863945 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Giuseppe Cattafi |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Giuseppe Cattafi |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5055447547 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-8500-8313 |
| authorships[13].author.display_name | Claudio Tondo |
| authorships[13].countries | IT |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210089474 |
| authorships[13].affiliations[0].raw_affiliation_string | Centro Cardiologico Monzino IRCCS |
| authorships[13].institutions[0].id | https://openalex.org/I4210089474 |
| authorships[13].institutions[0].ror | https://ror.org/006pq9r08 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210089474, https://openalex.org/I4210153126 |
| authorships[13].institutions[0].country_code | IT |
| authorships[13].institutions[0].display_name | Centro Cardiologico Monzino |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Claudio Tondo |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Centro Cardiologico Monzino IRCCS |
| authorships[14].author.id | https://openalex.org/A5087273064 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | STOP ClinicalService Centers |
| authorships[14].author_position | last |
| authorships[14].raw_author_name | 1STOP ClinicalService Centers |
| authorships[14].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.5281/zenodo.6337499 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Dataset related to the article "First-line therapy: insights from a real-world analysis of cryoablation in patients with atrial fibrillation" |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T06:51:31.235846 |
| primary_topic.id | https://openalex.org/T10065 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.6621999740600586 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2705 |
| primary_topic.subfield.display_name | Cardiology and Cardiovascular Medicine |
| primary_topic.display_name | Atrial Fibrillation Management and Outcomes |
| related_works | https://openalex.org/W4387497383, https://openalex.org/W3183948672, https://openalex.org/W3173606202, https://openalex.org/W3110381201, https://openalex.org/W2948807893, https://openalex.org/W2935909890, https://openalex.org/W2778153218, https://openalex.org/W2758277628, https://openalex.org/W1531601525, https://openalex.org/W2398757679 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.5281/zenodo.6337499 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306400562 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Zenodo (CERN European Organization for Nuclear Research) |
| best_oa_location.source.host_organization | https://openalex.org/I67311998 |
| best_oa_location.source.host_organization_name | European Organization for Nuclear Research |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I67311998 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | |
| best_oa_location.raw_type | dataset |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.5281/zenodo.6337499 |
| primary_location.id | doi:10.5281/zenodo.6337499 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4306400562 |
| primary_location.source.issn | |
| primary_location.source.type | repository |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Zenodo (CERN European Organization for Nuclear Research) |
| primary_location.source.host_organization | https://openalex.org/I67311998 |
| primary_location.source.host_organization_name | European Organization for Nuclear Research |
| primary_location.source.host_organization_lineage | https://openalex.org/I67311998 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | |
| primary_location.raw_type | dataset |
| primary_location.license_id | |
| primary_location.is_accepted | False |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.5281/zenodo.6337499 |
| publication_date | 2022-03-08 |
| publication_year | 2022 |
| referenced_works_count | 0 |
| abstract_inverted_index.7 | 92 |
| abstract_inverted_index.a | 13, 47, 54, 69, 193, 230, 244 |
| abstract_inverted_index.12 | 182 |
| abstract_inverted_index.13 | 84 |
| abstract_inverted_index.24 | 187 |
| abstract_inverted_index.26 | 122 |
| abstract_inverted_index.41 | 90 |
| abstract_inverted_index.56 | 82 |
| abstract_inverted_index.At | 202 |
| abstract_inverted_index.We | 45 |
| abstract_inverted_index.an | 104, 210, 217 |
| abstract_inverted_index.as | 68 |
| abstract_inverted_index.at | 181, 186 |
| abstract_inverted_index.be | 248 |
| abstract_inverted_index.by | 107, 227 |
| abstract_inverted_index.in | 18, 53, 113, 147, 229 |
| abstract_inverted_index.is | 33 |
| abstract_inverted_index.of | 16, 50, 64, 116, 206 |
| abstract_inverted_index.on | 209, 216 |
| abstract_inverted_index.or | 40 |
| abstract_inverted_index.to | 6, 250 |
| abstract_inverted_index.± | 83, 91 |
| abstract_inverted_index.10% | 205 |
| abstract_inverted_index.249 | 78 |
| abstract_inverted_index.76% | 185 |
| abstract_inverted_index.CBA | 65, 228, 242 |
| abstract_inverted_index.PVI | 106, 226, 245 |
| abstract_inverted_index.The | 172 |
| abstract_inverted_index.and | 57, 61, 98, 129, 134, 167, 184, 240, 255, 267 |
| abstract_inverted_index.any | 161 |
| abstract_inverted_index.can | 247 |
| abstract_inverted_index.for | 36, 72 |
| abstract_inverted_index.had | 192 |
| abstract_inverted_index.mm; | 93 |
| abstract_inverted_index.one | 156, 163, 168 |
| abstract_inverted_index.our | 222 |
| abstract_inverted_index.raw | 3 |
| abstract_inverted_index.the | 7, 59, 114, 117, 199 |
| abstract_inverted_index.was | 141, 179, 236 |
| abstract_inverted_index.(23% | 80 |
| abstract_inverted_index.(not | 159 |
| abstract_inverted_index.21.0 | 135 |
| abstract_inverted_index.6.8% | 214 |
| abstract_inverted_index.90.0 | 133 |
| abstract_inverted_index.CBA. | 108 |
| abstract_inverted_index.Data | 109 |
| abstract_inverted_index.This | 0 |
| abstract_inverted_index.data | 4 |
| abstract_inverted_index.four | 152 |
| abstract_inverted_index.from | 12, 175 |
| abstract_inverted_index.good | 260 |
| abstract_inverted_index.last | 203 |
| abstract_inverted_index.left | 87 |
| abstract_inverted_index.mean | 86 |
| abstract_inverted_index.min, | 136 |
| abstract_inverted_index.used | 249 |
| abstract_inverted_index.vein | 26 |
| abstract_inverted_index.well | 237 |
| abstract_inverted_index.were | 110, 132, 145, 208, 215 |
| abstract_inverted_index.when | 66 |
| abstract_inverted_index.with | 20, 38, 243, 253, 259 |
| abstract_inverted_index.(CBA) | 32 |
| abstract_inverted_index.(PVI) | 28 |
| abstract_inverted_index.1STOP | 118 |
| abstract_inverted_index.26.5% | 99 |
| abstract_inverted_index.73.5% | 94 |
| abstract_inverted_index.86.3% | 180 |
| abstract_inverted_index.Acute | 138 |
| abstract_inverted_index.acute | 261 |
| abstract_inverted_index.drug. | 219 |
| abstract_inverted_index.index | 105 |
| abstract_inverted_index.large | 48 |
| abstract_inverted_index.minor | 169 |
| abstract_inverted_index.seven | 148 |
| abstract_inverted_index.short | 264 |
| abstract_inverted_index.times | 131 |
| abstract_inverted_index.treat | 251 |
| abstract_inverted_index.trial | 271 |
| abstract_inverted_index.using | 29 |
| abstract_inverted_index.(6.8%) | 191 |
| abstract_inverted_index.99.8%. | 142 |
| abstract_inverted_index.atrial | 21, 43, 73, 88, 96, 101, 176, 232, 257 |
| abstract_inverted_index.cohort | 49 |
| abstract_inverted_index.during | 198 |
| abstract_inverted_index.mainly | 34 |
| abstract_inverted_index.months | 183 |
| abstract_inverted_index.record | 1 |
| abstract_inverted_index.repeat | 194 |
| abstract_inverted_index.safety | 60 |
| abstract_inverted_index.times, | 266 |
| abstract_inverted_index.total, | 77 |
| abstract_inverted_index.women; | 81 |
| abstract_inverted_index.years; | 85 |
| abstract_inverted_index.(2.8%), | 150 |
| abstract_inverted_index.Italian | 123 |
| abstract_inverted_index.applied | 67 |
| abstract_inverted_index.article | 8 |
| abstract_inverted_index.attack, | 166 |
| abstract_inverted_index.freedom | 174 |
| abstract_inverted_index.months. | 188 |
| abstract_inverted_index.patient | 234 |
| abstract_inverted_index.period. | 201 |
| abstract_inverted_index.profile | 63 |
| abstract_inverted_index.related | 5 |
| abstract_inverted_index.safety. | 269 |
| abstract_inverted_index.setting | 56 |
| abstract_inverted_index.success | 140 |
| abstract_inverted_index.treated | 52 |
| abstract_inverted_index.whereas | 213 |
| abstract_inverted_index.ablation | 31, 196 |
| abstract_inverted_index.analysis | 15 |
| abstract_inverted_index.catheter | 195 |
| abstract_inverted_index.centers. | 125 |
| abstract_inverted_index.contains | 2 |
| abstract_inverted_index.diameter | 89 |
| abstract_inverted_index.efficacy | 62 |
| abstract_inverted_index.effusion | 158 |
| abstract_inverted_index.examined | 58 |
| abstract_inverted_index.insights | 11 |
| abstract_inverted_index.ischemic | 165 |
| abstract_inverted_index.observed | 146 |
| abstract_inverted_index.patients | 19, 37, 51, 79, 149, 190, 207, 252 |
| abstract_inverted_index.project, | 120 |
| abstract_inverted_index.reserved | 35 |
| abstract_inverted_index.strategy | 246 |
| abstract_inverted_index.success, | 263 |
| abstract_inverted_index.therapy, | 212 |
| abstract_inverted_index.therapy: | 10 |
| abstract_inverted_index.vascular | 170 |
| abstract_inverted_index.Seventeen | 189 |
| abstract_inverted_index.collected | 111 |
| abstract_inverted_index.evaluated | 46 |
| abstract_inverted_index.follow-up | 200 |
| abstract_inverted_index.framework | 115 |
| abstract_inverted_index.involving | 121 |
| abstract_inverted_index.isolation | 27 |
| abstract_inverted_index.procedure | 128, 197, 265 |
| abstract_inverted_index.requiring | 160 |
| abstract_inverted_index.transient | 153, 164 |
| abstract_inverted_index.treatment | 71 |
| abstract_inverted_index.underwent | 103 |
| abstract_inverted_index.acceptable | 268 |
| abstract_inverted_index.cardiology | 124 |
| abstract_inverted_index.effective, | 239 |
| abstract_inverted_index.first-line | 70, 231 |
| abstract_inverted_index.follow-up, | 204 |
| abstract_inverted_index.including: | 151 |
| abstract_inverted_index.paralyses, | 155 |
| abstract_inverted_index.paroxysmal | 95, 254 |
| abstract_inverted_index.persistent | 100, 256 |
| abstract_inverted_index.population | 235 |
| abstract_inverted_index.procedural | 139, 262 |
| abstract_inverted_index.promising. | 241 |
| abstract_inverted_index.real-world | 14, 55, 224 |
| abstract_inverted_index.recurrence | 178 |
| abstract_inverted_index.tolerated, | 238 |
| abstract_inverted_index."First-line | 9 |
| abstract_inverted_index.</strong>In | 76, 221 |
| abstract_inverted_index.cryoballoon | 30 |
| abstract_inverted_index.experience, | 225 |
| abstract_inverted_index.fluoroscopy | 130 |
| abstract_inverted_index.multicenter | 223 |
| abstract_inverted_index.pericardial | 157 |
| abstract_inverted_index.symptomatic | 42 |
| abstract_inverted_index.cryoablation | 17 |
| abstract_inverted_index.fibrillation | 177, 233, 258 |
| abstract_inverted_index.<strong>Aims: | 24 |
| abstract_inverted_index.Kaplan--Meier | 173 |
| abstract_inverted_index.complication. | 171 |
| abstract_inverted_index.complications | 144 |
| abstract_inverted_index.diaphragmatic | 154 |
| abstract_inverted_index.fibrillation" | 22 |
| abstract_inverted_index.fibrillation) | 102 |
| abstract_inverted_index.fibrillation. | 44, 74 |
| abstract_inverted_index.fibrillation; | 97 |
| abstract_inverted_index.prospectively | 112 |
| abstract_inverted_index.registration: | 272 |
| abstract_inverted_index.respectively. | 137 |
| abstract_inverted_index.(NCT01007474). | 274 |
| abstract_inverted_index.antiarrhythmic | 218 |
| abstract_inverted_index.intervention), | 162 |
| abstract_inverted_index.</strong>Median | 127 |
| abstract_inverted_index.ClinicalService | 119 |
| abstract_inverted_index.anticoagulation | 211 |
| abstract_inverted_index.drug-intolerant | 41 |
| abstract_inverted_index.drug-refractory | 39 |
| abstract_inverted_index.<strong>Clinical | 270 |
| abstract_inverted_index.<strong>Methods: | 75 |
| abstract_inverted_index.<strong>Results: | 126 |
| abstract_inverted_index.</strong>Pulmonary | 25 |
| abstract_inverted_index.<strong>Conclusion: | 220 |
| abstract_inverted_index.Acute/periprocedural | 143 |
| abstract_inverted_index.</strong>clinicaltrials.gov | 273 |
| abstract_inverted_index.<em><strong>Abstract</strong></em> | 23 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 15 |
| citation_normalized_percentile |